Data Bridge Market Research analyses that the cephalosporin market was valued at USD 18.04 billion in 2021 and is expected to reach USD 23.70 billion by 2029, registering a CAGR of 3.47% during the forecast period of 2022 to 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Get Sample PDF Brochure: https://www.databridgemarketresearch.com/request-a-sample/?dbmr=glo...

Some of the major players operating in the cephalosporin market are:

F. Hoffmann-La Roche Ltd. (Switzerland)

Mylan N.V. (U.S.)

Teva Pharmaceutical Industries Ltd. (Ireland)

Sanofi (France)

Pfizer Inc. (U.S.)

GlaxoSmithKline plc (U.K.)

Novartis AG (Switzerland)

Merck & Co., Inc. (U.S.)

AstraZeneca (U.K.)

Johnson & Johnson Private Limited (U.S.)

Aurobindo Pharma (India)

Cipla Inc. (U.S.)

Lannett (U.S.)

Bausch Health Companies Inc. (Canada)

Sun Pharmaceutical Industries Ltd. (India)

Novo Nordisk A/S (Denmark)

Currax Pharmaceuticals LLC (U.S.)

Eisai Co., Ltd. (Japan)

Takeda Pharmaceutical Company Limited (Japan)

According to a World Health Organization (WHO) research from February 2018, the belt of Sub-Saharan Africa, running from Senegal in the west to Ethiopia in the east, has the largest burden of this disease. Every year, some 30,000 instances are recorded from that region. Cephalosporin antibiotics are a class of broad-spectrum, semi-synthetic beta-lactam antibiotics that are commonly used to treat bacterial infections, including bacterial meningitis, otitis media, pneumonia, tuberculosis, upper respiratory tract infections, eye infections, sinusitis, urinary tract infections, skin infections, and sexually transmitted diseases. Cephalexin, cefixime, cefaclor, ceftriaxone, and cefdinir are the most regularly used cephalosporins.

Cephalosporin antibiotics are beta-lactam antibiotics that work similarly to penicillin. These broad-spectrum antibiotics are used to treat various bacterial infections, including pneumonia, kidney infections, bone infections, meningitis, and sexually transmitted diseases (STDs). There are five generations of cephalosporin medicines now, each having a slightly different antibacterial range. These medications are also classified based on how they are administered, excreted, absorbed, and how long the cephalosporin has an effect on the body.

Cephalosporin Market Dynamics

Drivers

Increasing prevalence of respiratory tract infections

The increasing prevalence of respiratory tract infections across the globe will fuel industry growth. Lower respiratory tract infection and pneumonia are two of the main causes of death, accounting for approximately 4 million deaths yearly, according to The Global Impact of Respiratory Disease report from 2017. Furthermore, pneumonia claimed the lives of 920,136 children under the age of five in 2015, accounting for 15% of all deaths in this age group. Streptococcus pneumonia is still the most common bacterial cause of pneumonia, affecting 393,000 children under the age of five in 2015.

Increase in the number of strategic partnership

The rise in number of strategic partnerships is anticipated to create new market growth opportunities. Various groups throughout the world are working to enhance antibiotic therapy development and delivery. The Global Antibiotic Research and Development Partnership (GARDP), a non-profit R&D organization founded by the Drugs for Neglected Disease Initiative (DNDi) and the World Health Organization (WHO), is one such program. It focuses on expanding R&D of new antimicrobial diagnostics and agents through public-private collaborations. The expansion of the cephalosporin market is estimated to be aided by the formation of these partnerships.

Moreover, the market’s growth is fueled by rising technological advancement and emerging new markets. These factors will provide beneficial opportunities for the cephalosporin market growth. Also, the increase in the number of research and development activities will provide beneficial opportunities for the cephalosporin market’s growth.

Restraints/Challenges

On the other hand, the high cost of drug development and distribution will obstruct the market’s growth rate. The lack of healthcare infrastructure in developing economies and the dearth of skilled professionals will challenge the cephalosporin market. Additionally, lack of awareness among people and increasing Food and Drug Administration (FDA) recalls will act as restrain and further impede the growth rate of market during the forecast period of 2022-2029.

This cephalosporin market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the cephalosporin market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Patient Epidemiology Analysis

Cephalosporin market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analyses of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

Access Full Report: https://www.databridgemarketresearch.com/reports/global-cephalospor...

COVID-19 Impact on Cephalosporin Market

Since its emergence in December 2019, the COVID-19 virus has spread to nearly every country on the planet, prompting the World Health Organization (WHO) to declare it a public health emergency. COVID-19, a new coronavirus, was identified as the causal agent in pneumonia cases. This virus spread quickly over the world, killing a large number of people. COVID-19 was labelled a global pandemic by the World Health Organization (WHO) in March 2020, and rigorous measures to prevent the disease’s spread were recommended. Since then, the pandemic has delayed the expansion of the healthcare sector and disrupted the supply chain.

Furthermore, governments in many nations had imposed nationwide lockdowns to halt the spread of COVID-19. Similarly, healthcare organizations in numerous nations throughout the world were having difficulty continuing their supply chain activities. The supply chain slowness hampered the cephalosporin market. On the bright side, the cephalosporin market is likely to improve as respective government bodies lifted the enforced lockdown restrictions. Various sectors are anticipated to rebound quickly post COVID-19 pandemic due to the wide number of applications they serve. As a result, the market is projected to stabilize in the future.

Global Cephalosporin Market Scope

The cephalosporin market is segmented on the basis of type, indication, mode of purchase, dosage form, drug type, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

First-Generation Cephalosporins

Second-Generation Cephalosporins

Third-Generation Cephalosporins

Fourth-Generation Cephalosporin

Fifth-Generation Cephalosporins

Others

Indication

Skin Infection

Urinary Tract Infections

Strep Throat

Ear Infections

Pneumonia

Sinus Infections

Meningitis

Gonorrhoea

Others

Mode of Purchase

Prescription

Over-the-Counter

Dosage Form

Tablets

Capsules

Powder

Liquid

Gels

Suppositories

Others

Drug Type

Branded

Generics

Route of Administration

Oral

Parenteral

Others

End-Users

Hospitals

Specialty Clinics

Homecare

Others

Distribution Channel

Hospital Pharmacy

Retail Pharmacy

Online Pharmacy

Others

Request for Full TOC: https://www.databridgemarketresearch.com/toc/?dbmr=global-cephalosp...

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter’s five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Top DBMR Healthcare Reports:

https://www.einpresswire.com/article/577768736/prophylaxis-of-organ...

https://www.einpresswire.com/article/577770544/fitness-app-market-g...